Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06188221 · ClinicalTrials.gov registry record · NA

Does Adding Lidocaine to Corticosteroid Injections Reduce Pain Intensity in Hand Surgery

A NA study of Carpal Tunnel Syndrome and Trigger Finger, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06188221 is a NA study of Carpal Tunnel Syndrome and Trigger Finger that has completed, run by University of Texas at Austin. The registered enrollment target is 40 participants, below the 221-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06188221, a NA study of Carpal Tunnel Syndrome and Trigger Finger, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to determine whether adding Lidocaine to Corticosteroid injections reduce pain intensity in hand surgery.

Interventions

  • DRUG Lidocaine
  • DRUG Corticoids

Study Locations (1)

Texas

  • University of Texas Health Austin (UTHA) - Austin

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-02-01
Est. Completion 2023-07-01
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT06188221

The ClinicalTrials.gov registry entry for NCT06188221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (82% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine is the first listed.

NCT06188221 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06188221 about?

NCT06188221 is a clinical study titled "Does Adding Lidocaine to Corticosteroid Injections Reduce Pain Intensity in Hand Surgery". The purpose of this study was to determine whether adding Lidocaine to Corticosteroid injections reduce pain intensity in hand surgery.

What is the current status of trial NCT06188221?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-02-01. Estimated completion is 2023-07-01.

What conditions does trial NCT06188221 study?

This clinical trial studies the following conditions: Carpal Tunnel Syndrome, Trigger Finger, Hand Osteoarthritis.

What interventions are being tested in trial NCT06188221?

The interventions under investigation include: Lidocaine (DRUG), Corticoids (DRUG).

Who is sponsoring clinical trial NCT06188221?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06188221 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carpal Tunnel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.